» Authors » Kevin Korenblat

Kevin Korenblat

Explore the profile of Kevin Korenblat including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 307
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jabboure F, Darcy M, Sauk S, Abrams Z, Korenblat K, Kim S, et al.
J Vasc Interv Radiol . 2025 Jan; PMID: 39848327
Purpose: To evaluate the impact of transjugular intrahepatic portosystemic shunt (TIPS) on outcomes of recurrent portal hypertension (PH) after liver transplant (LT). Materials And Methods: From a cohort of 1,846...
2.
Afzal A, Kesavan P, Suhong L, Gage B, Korenblat K, Schoen M, et al.
J Hematol . 2024 Jul; 13(3):71-78. PMID: 38993731
Background: Non-variceal hemorrhage in patients with chronic liver disease (CLD) increases morbidity, mortality, and healthcare costs. There are limited data on risk factors for non-variceal hemorrhage in the CLD population....
3.
Chin R, Schiff J, Bommireddy A, Kang K, Andruska N, Price A, et al.
Clin Transl Radiat Oncol . 2023 Jul; 41:100627. PMID: 37441543
Purpose: Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) with optional online adaptation has shown promise in delivering ablative doses to unresectable primary liver cancer. However, there remain limited data on...
4.
Chin R, Bommireddy A, Fraum T, Ludwig D, Huang Y, Zoberi J, et al.
Adv Radiat Oncol . 2022 Jul; 7(4):100948. PMID: 35814852
Purpose: Yttrium-90 (90Y) radioembolization with an escalated dose has been shown to improve clinical outcomes compared with standard dose radioembolization, but there are few data on the local control of...
5.
Afzal A, Gage B, Suhong L, Schoen M, Korenblat K, Sanfilippo K
J Thromb Haemost . 2022 May; 20(7):1610-1617. PMID: 35491428
Background: Patients with chronic liver disease (CLD) often present with an elevated international normalized ratio (INR). Although elevated INR reflects a higher risk of hemorrhage among warfarin users, its clinical...
6.
Kim S, Lee K, Sauk S, Korenblat K
Korean J Radiol . 2017 Mar; 18(2):345-354. PMID: 28246514
Objective: Although a transjugular intrahepatic portosystemic shunt (TIPS) is commonly placed to manage isolated gastric varices, balloon-occluded retrograde transvenous obliteration (BRTO) has also been used. We compare the long-term outcomes...
7.
Airhart S, Cade W, Jiang H, Coggan A, Racette S, Korenblat K, et al.
J Clin Endocrinol Metab . 2015 Dec; 101(2):504-12. PMID: 26652763
Context: Excessive cardiac long-chain fatty acid (LCFA) metabolism/storage causes cardiomyopathy in animal models of type 2 diabetes. Medium-chain fatty acids (MCFAs) are absorbed and oxidized efficiently. Data in animal models...
8.
Meyer A, Green M, Pautler H, Korenblat K, Deal E, Thoelke M
Ann Pharmacother . 2015 Nov; 50(2):113-7. PMID: 26586854
Background: The efficacy of vitamin K in lowering an elevated INR in the setting of cirrhosis is not well established. Objectives: The purpose of this investigation is to determine the...
9.
Coverstone E, Korenblat K, Crippin J, Chapman W, Kates A, Zajarias A
Case Rep Cardiol . 2014 Nov; 2014:325136. PMID: 25431682
The combination of severe aortic stenosis and end-stage liver disease increases the morbidity and mortality of surgical aortic valve replacement or orthotopic liver transplantation resulting in a prohibitive operative risk....
10.
Blinder M, Geng B, Lisker-Melman M, Crippin J, Korenblat K, Chapman W, et al.
Hematol Rep . 2013 Jul; 5(1):1-4. PMID: 23888237
Sickle cell disease can lead to hepatic complications ranging from acute hepatic crises to chronic liver disease including intrahepatic cholestasis, and iron overload. Although uncommon, intrahepatic cholestasis may be severe...